Clinical Trial Update: Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating salvage therapy with venetoclax and decitabine for relapsed/refractory acute myeloid leukemia. The study also involves myelody…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: AML, MDS | Phase 2 | Status: RECRUITING